A Phase II Study of Bevacizumab and High-dose Interleukin-2 in Patients With Metastatic Renal Cell Carcinoma: A Cytokine Working Group (CWG) Study
暂无分享,去创建一个
M. Atkins | J. Sosman | M. Regan | I. Puzanov | T. Crocenzi | M. Ernstoff | W. Urba | J. Dutcher | U. Vaishampayan | D. McDermott | Joseph I. Clark | B. Curti | K. Margolin | U. B. Dandamudi | M. Ghebremichael | N. Crosby | U. Dandamudi